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Serum protease, also known  as plasmin and  fibrinolysin, has  been  shown  to  be 
present in an inactive state as a natural constituent of mammalian blood. Numerous 
activating agents have been recorded for this enzyme since Delezenne and Pozerski 
(1)  first  demonstrated  the  proteolytic activity of  serum  treated  with  chloroform. 
This observation has been confirmed by other investigators (2-4). Jobling and Peter- 
sen  (5-6) had reported that adsorption of serum protease inhibitors by various ma- 
terials, kaolin, starch paste, agar, and bacteria, resulted in demonstrable proteolytic 
activity of the  serum.  More recently, activators from  tissue and  serum have  been 
recorded (7-12). The most rapid and potent activators of serum protease have been 
prepared from  bacterial sources, notably the  so called streptokinase, from  strepto- 
coccal  culture  filtrates  (4,  13)  and  staphylokinase  from  staphylococcal  cultures 
(14--15).  The activation pattern of the bacterial products, however, varies with  the 
species of animals used as a  source of inactive protease. Streptokinase has been re- 
garded as the only efficient activator of human  serum protease and staphylokinase 
as  the  best activator of  the proteases of rabbits, guinea pigs,  dogs, and  monkeys 
(15-19). 
Antigen-antibody combinations also have been reported as activators for serum 
protease. In 1915, Jobling et  al. (20) concluded that activation of serum proteolytic 
enzymes resulted if a  precipitin reaction occurred in serum or if particulate matter 
was added to  the serum. Bronfenbrenner  (21, 22)  in similar studies, concluded that 
proteolytic enzymes of fresh serum were released either by the non-specific mechan- 
ical adsorption of inhibitors or by the inactivation of serum inhibitors as a  result of 
the  specific combination of  antigen  and  antibody.  Ungar  and  Mist  (23)  reported 
that  the protease of guinea pig immune serum  could be activated by the addition 
of  the  specific antigen.  Recently,  Geiger  (24)  demonstrated  that  the  protease  of 
immune rabbit serum could be activated by some but not all, of the various antigens 
he employed as sensitizing agents. 
Some of the earlier investigators referred to above (5, 6, 20-22)  had regarded the 
activation of serum protease to be the result of the removal of inhibitors from  the 
serum. It has repeatedly been shown  that the inhibitory power of whole serum for 
active protease is  associated with  the  albumin fraction  (25-27).  However,  the ac- 
cumulated evidence now indicates that serum protease is not in  combination with 
the known protease inhibitors of serum  but is in  the form  of an  inactive protease 
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precursor which  can  be  converted  to  the proteolytic state  (4,  10,  19,  25,  28-30). 
The serum fractionation methods of dilution and acidification,  or of dialysis and salting- 
out have shown the precursor to be in the resulting crude euglobulin fraction. This 
fraction can be further purified by acid extraction (of. Christensen and Smith (31) 
for references). That inhibitors of the bacterial activating agents may occur in serum 
has been indicated by the work of Kaplan (30)  who reported an anfistreptokinase 
factor  distinct from  that  of  the  normal  inhibitor found  in  the  albumin fraction. 
Characterization of  the serum protease indicates it to be a  non-dialyzable protein 
enzyme, water-insoluble and saline-soluble with an optimal pH range of 7.2-7.6, an 
optimal temperature of  37°C.,  and  with  the ability to effect proteolysis of fibrin, 
fibrinogen, gelatin, and casein, all commonly employed substrates (28, 29, 32, 33). 
Because antigen-antibody reactions have been reported as serum protease activa- 
tors, attempts have been made to assign a  role to the active enzyme in systemic or 
local aliergic reactions. The suggestion has been made that it plays a part in anaphy- 
lactic shock,  (a)  through its direct activation (23,  34,  35),  (b)  through the produc- 
tion of toxic substances  (5, 6,  20-22),  or  (c)  as the cause of a  release of histamine 
(36, 37).  Some  investigators also  have  implied that  protease may  be  involved in 
certain types of local hypersensitivity (38-41). 
Grob (26)  had demonstrated that subcutaneous injections of trypsin produce local 
necrotic lesions. Dragstedt and Wells (42)  showed that Arthus-Iike lesions are pro- 
duced by intracutaneous injections of trypsin. Ungar and Damgaard  (41)  suggested 
that activated serum protease may be involved in the Arthus reaction. 
In following the line of reasoning just outlined our inability to demonstrate 
any in vitro activation of immune serum protease with its antigen in preliminary 
experiments has led us to a  reinvestigation of the problem of protease activa- 
tion  by  an  antigen-antibody system.  Since  egg  albumin  readily elicits ana- 
phylaxis and the Arthus phenomenon in rabbits and guinea pigs, this was used 
as the  sole antigen  in  our  investigations. The present  report deals with  our 
inability to activate serum protease through  the agency of this antigen-anti- 
body system. 
Materials  and Methods 
Buffered Saline.--The solution  used as solvent or diluent in all of the experiments  was 
prepared by adding 1 volume of 0.15 x( phosphate btiffer of pH 7.4 to 9 volumes of 0.9 per cent 
saline. No change in pH resulted from this dilution. 
Antigens.--Four  times crystallized egg albumin was prepared according to the procedure 
of Cole (43) and used as antigen in many of the experiments. Merck's soluble egg albumin was 
prepared in sterile solution and was also used as antigen in guinea pig experiments. 
Immune Sera.--Rabbit antisera were prepared against the crystalline egg albumin and the 
approximate antibody content of such antisera was determined by the method of Culbertson 
and Seegal (44). 
Immune guinea pig sera were prepared as described  elsewhere in the text. The presence 
of precipitable antibodies was determined by the qualitative ring test technic. 
Sources of Serum Proteases.--Fresh, whole sera or the euglobulin  fractions thereof were 
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sources were stored at  -20°C. until used. Fresh, whole normal human serum was obtained 
from donors whenever required. Human euglobulin protease precursor fraction was prepared 
from plasma less than 24 hours old. The plasma was recalcified  and the fibrin removed. The 
resulting serum was dialyzed for 2 days against running tap water and 1 day in frequently 
changed distilled water at  4°C.  The  euglobulin precipitate obtained in  this manner was 
redissolved in an amount of buffer equal to one-tenth of the original plasma volume. Spon- 
taneous activation of the protease never occurred in any of the samples prepared in  this 
manner. 
Rabbit  eugiobulin precursor fractions were  prepared from fresh rabbit  antiovalbumin 
serum. In initial experiments  it was found that the euglobulin fraction contained no appreciable 
antibody as compared with the original immune serum. To overcome this difficulty,  the whole 
globulin fraction of the immune serum was precipitated by half saturation with ammonium 
sulfate. The  resulting precipitate was collected, dialyzed, and redissolved in  a  volume of 
buffered saline to give a  concentration approximating that of the original serum. With this 
procedure there was only a negligible  decrease of the original serum precipitin titer. 
Whole guinea pig serum was used according to the procedures described by Ungar and 
Mist (23). Two sets of animals were employed, the first all males averaging 250 gin., while the 
second set consisted of animals of both sexes, all above 500 gin. in weight. 
Protease Activalors.--Streptoklnase  1 was  used  as  the  activator for human  and  rabbit 
whole serum as well as for the human euglobulin precursor fraction. 250-350  units of strepto- 
kinase were added per milliliter of the sample to be activated. 
Staphylokinase was obtained by the method of Gerhelm eta/.  (14). The crude precipitate 
isolated by this procedure was redissolved in buffered saline and used to activate guinea pig 
serum and  the euglobulin fraction. 0.1  ml.  of the staphylokinase solution was added for 
every 0.5 ml. of the sample to be tested. 
Protease Assay Method.--Serum protease activity was determined by measuring the in- 
crease of acid-soluble nitrogen produced by this enzyme from a  purified casein substrate. 
Since it was found, in agreement with Remmert and Cohen (29), that commercial casein was 
unsuitable for this purpose, their method of preparing milk casein was employed. This six 
times reprecipitated substrate gave reproducible results with different batches. 
The actual assay method consisted of adding 0.5 ml. of the protease sample to 2 ml. of a 
4 per cent casein solution with a drop of toluene added as a preservative. Immediately, 1 ml. 
of the complex was removed and this was regarded as the zero hour blank. The remainder of 
the enzyme-substrate mixture was incubated in a 37°C. water bath for 18 hours. 1 ml. of the 
mixture was then removed and added to 0.5 nil.  of distilled water and precipitated with 4 
ml. of 10 per cent trichloroacetic acid. Mtera half-hour minimum contact period at room 
temperature, the solution was filtered through a  No.  5  Whatman paper. The acid-soluble 
nitrogen content of the filtrate was determined by the technic of Koch and McMeekin (45). 
The  nesslerized solution  was  read  within  7  minutes in  a  Klett-Summerson photoelectric 
colorime~:er using a No. 54 green filter. The previously obtained zero hour blank reading was 
subtracted from the 18 hour reading. This corrected reading was then interpolated from a 
previously calibrated curve to obtain the measure of proteolytic activity in terms of units 
per total digest. 
A  standard  curve  was  obtained  through  the  use  of a  streptokinase-activated human 
euglobuliu fraction. Serial dilutions of this preparation were tested for activity on the casein 
substrate. The means of at least three determinations at each protease concentration were 
plotted against dilutions of protease. A linear relationship between the relative enzyme con- 
eentration and non-protein nitrogen liberated was obtained over a  limited range. Values at 
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each end of the linear portion of the curve were expressed as <  0.5 or >  15.0 units. Under 
these conditions, one proteolytic unit was arbitrarily  defined as that amount of protease 
producing an increment of 100 t~g. of acid-soluble nitrogen in a medium of 4 per cent casein 
in 18 hours at 37°C. 
For the determination of serum protease activity  the fibrinogenolytic method of Ungar 
and Mist  (23) was employed in some instances also. Bovine fibrlnogen, fraction I  (Armour 
and Co.), and bovine thrombin (The Upjohn Co.) were utilized as the clot-producing agents 
in this method. Evidence of fibrinogenolysis  was recorded here merely as the highest dilution 
of protease which resulted in failure to clot upon the addition of 0.1 ml. of the thrombin 
solution containing 25 units per ml. Appropriate saline and thrombin controls were used with 
each sample run as a check of the efficacy of the system. 
TABLE  I 
Comparison oJ Protease A ssay Methods 
Protease dilutions 
Undiluted 
1-4 
1-8 
1-16 
1-32 
1-40 
1-64 
1-80 
1-160 
Saline control 
Fibrlnogenolytie  method 
Clot formation* 
t 
+ 
+ 
+ 
+ 
Casein proteolysls  method 
Proteolytie units 
>15 
>15 
>15 
>15 
12.7 
10.3 
7.8 
5.3 
3.7 
*-  --  no clot formation,  indicating  fibrinogenolysis; +  =  clot formation, indicating 
no fibrinogenolysis. 
Protease Controls.--As a control for the presence and availability of the protease precursor, 
streptokinase or staphylokinase was added to the appropriate samples. Saline was included 
as a control in order to detect spontaneous or non-specific  activation of the samples. 
EXPERIMENTAL RESULTS 
Comparison of Protease Assay Methods.--Some of the results obtained in this 
study were contrary to the results obtained by other workers who employed 
the fibrinogenolytic  method for assaying serum protease (23). This method was 
compared with our casein proteolysis assay procedure for protease. The com- 
parative data  shown in Table I  were  obtained on a  streptokinase-activated 
human euglobulin fraction. Although proteolysis was evident with the higher 
concentrations of protease, using both methods, the casein procedure appeared 
to be the more sensitive for detection of smaller amounts of activated protease. 
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However, when the fibrinogenolytic test mixtures were incubated 2  hours or 
more after the thrombin had been added, complete dissolution of the clot was 
apparent in all tubes including the saline control. This probably indicated the 
presence of protease precursor or protease contaminants in the components of 
this particular system. That the sodium chloride, per se, had no effect on clot 
lysis or protease activation has been made plain  by the  work of Lewis and 
Ferguson  (19).  This  was  also  demonstrated  by some of  our  experiments  in 
which both methods of assay were employed. When the euglobulin fraction of 
guinea pig serum was added to fibrinogen, a clot formed in some instances prior 
to the addition of thrombin. This again suggested that contaminants may be 
found in the materials used in the fibrinogenolytic assay method. By employing 
the casein digestion methods, these variables are apparently obviated because 
the substrate is obtained from a source unlikely to contairi either blood-clotting 
TABLE II 
Inhibition of Human Protease by Various Fractions 
Fraction tested*  Inhibition of active protease~: 
Normal rabbit euglobulin  ............................. 
"  "  albumin .............................. 
"  human  "  .............................. 
"  "  "  (4 X concentration) ............ 
Crystalline egg  "  (4.2 per cent) .................. 
p~" Geni 
o 
48 
o-5 
41 
* Active protease incubated with equal volume of test fraction for 1 hour at 20 C  °. 
Data obtained with casein digestion method. 
factors, protease, or protease-inhibitor fractions. The heating of the substrate 
during its preparation also would tend to inactivate such contaminants. It was 
also noted that in no case did the protease samples ever show fibrinogenolysis 
without  demonstrating  definite  casein proteolysis. 
E~ect  of  Various  Albumins  as Protease Inhibitors.--The  possibility that the 
egg albumin antigen  was a  protease inhibitor  was investigated.  Some serum 
albumin fractions were also assayed for protease-inhibiting activity. The serum 
fractions  were  prepared  by  ammonium  sulfate  fractionation.  Streptokinase- 
activated human euglobulin protease was incubated at room temperature for 
1 hour with equal amounts of the fraction to be tested. Samples of the protease- 
inhibitor mixture were then assayed for casein proteolysis. The results shown 
in Table II indicate the percentage of protease inhibition by the various frac- 
tions. Although  the crystalline egg albumin exhibited significant inhibition of 
the protease, it is to be noted that the concentration  of albumin used in this 
experiment was at least 100 times greater than any concentration employed in 
the subsequent protease activation experiments. The lack of inhibition by the 444  ACTIVATION  OF  SERUM  PROTEASE 
human  albumin fractions and the marked inhibition by the rabbit and egg 
albumin fractions suggest a species specificity of antiproteases. Although Lewis 
and Ferguson (25) could not demonstrate any species specificity of whole serum 
antiproteases for their homologous proteases, Guest et al. (46) reported marked 
species variations in the inhibitory effects of sera on bovine protease. Duthie 
and Lorenz (47) reported marked species variation in the antitryptic power of 
different animal species with little variation in the sera of individual members 
of the same species. It is apparent that results obtained with serum protease 
and  its  inhibitors will  vary,  depending  on the  experimental conditions em- 
ployed as well as on the origin and manner of preparation of the protease and 
the protease inhibitors. 
Studies  on Human  Protease.--Experiments  were carried  out  to  determine 
whether precipitin reactions or the addition of preformed precipitates as a form 
of particulate matter to serum  would activate the protease as had been re- 
ported by earlier investigators. These reports could not be substantiated when 
either whole immune  or normal  serum was  used  as protease sources.  Since 
whole serum normally contains protease inhibitors, it was deemed necessary to 
perform  the  activation  experiments  under  as  ideal  conditions  as  possible. 
Therefore serum fractions were employed which were known to be free of any 
normal protease inhibitors. These precursor  fractions were also shown to be 
easily converted to active protease by a  known activator, streptokinase. Even 
under these conditions no activation of the protease  could be demonstrated 
such as was evidenced by the following observations:-- 
A mixture of immune rabbit globulin and its antigen at the equivalence point 
and human  euglobulin protease precursor was  incubated for  15  minutes  at 
37  ° C. followed by overnight incubation at 4 ° C. Saline and streptokinase con- 
trols were run simultaneously. The supernates and the precipitates that formed 
were  then  tested  separately  for  casein  proteolysis.  No  proteolytic activity 
could be demonstrated by the antigen-antibody euglobulin supernatant mix- 
ture, the precipitates, or the saline control. The human euglobulin preparation 
incubated with streptokinase under identical conditions exhibited strong casein 
proteolysis. 
Since a known precursor fraction could not be activated during the occurrence 
of an  antigen-antibody reaction,  attempts  to  activate  the  human  protease 
precursor fraction with a preformed antigen-antibody precipitate were carried 
out for two reasons: first, to determine whether particulate materials such as 
preformed precipitate could activate the precursor fraction and, second, because 
of the opinion of Opie (48) that an antigen-antibody precipitate is essential for 
the Arthus phenomenon. 
Antigen-antibody precipitates were prepared aseptically and washed three 
times with sterile saline before use. In most of the experiments the precipitates 
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the precipitates obtained from the antigen and the antibody excess zones were 
employed. In every instance the supernate from the precipitate obtained in this 
manner consistently yielded negative results when assayed for protease activity. 
Portions of these washed precipitates were then mixed with human euglobulin 
protease  precursor  and  incubated  under  various conditions.  The  variables 
tested in these experiments were the temperature (4  ° C., 20  °  C.), duration of 
contact  (5 minutes to 24 hours), and the protease precursor  itself. The pre- 
cursor was derived from six separate blood samples obtained from four normal 
human beings. Aliquots of the supernate mixtures and of the precipitate mix- 
tures were then tested for casein proteolysis. No proteolytic activity could be 
demonstrated in any experiment with either of them. The control tubes con- 
sisting of saline in place of the precipitate were also negative while the strepto- 
kinase control tubes always showed the conversion of the precursor to an ex- 
tremely active protease. 
Since activation is  dependent on whether the whole serum or euglobulin 
fraction is used, the preformed precipitates also were tested on various samples 
of fresh human serum. Owing to the presence of protease inhibitors in whole 
serum,  the 3  minute contact  time of Ungar and  Mist  (23)  was  employed. 
Using their procedure for isolating the euglobulin fraction which they found 
contains the protease,  the fraction was tested for casein proteolytic activity. 
To check the possibility of any activated protease being adsorbed onto the 
precipitate,  the precipitates in some of the experiments were centrifuged off 
after the stated contact period and also tested for casein proteolysis. The usual 
controls  of  saline and  streptokinase  were  included in  the  experiments.  On 
assay,  the  precipitates,  the  isolated  euglobulin fraction  of  the  precipitate- 
treated serum, and saline-treated serum were shown to be devoid of proteolytic 
activity. The euglobulin fractions from the streptokinase-treated sera always 
exhibited marked casein proteolysis. 
As an incidental part of this study, the possibility that active protease could 
be  adsorbed  onto  the  preformed  precipitate  was  investigated.  Preformed 
precipitates were added to various concentrations of a streptokinase-activated 
human euglobulin protease  and  incubated  at  different time  intervals.  The 
supernates were separated from the precipitates as completely as possible and 
both preparations were tested for casein proteolysis. In no case did the pre- 
cipitates ever show any proteolytic activity beyond that attributable to the 
small amount of supernate left in contact with the precipitate. The supernates 
from these  tests,  as well,  remained unchanged in  their proteolytic activity. 
Studies on Immune Rabbit Serum Protease.--Initial experiments consisted of 
attempts to demonstrate the activation of the protease of an immune rabbit 
serum or immune rabbit globulin with its homologous antigen. The rabbit sera 
and the globulins prepared from the sera were always titered for the presence 
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rabbits which had exhibited a  strong Arthus reaction at the end of the course 
of immunization. 
Crystalline  egg  albumin  was  added  to  fresh  rabbit  antisera  and/or  the 
immune globulin fraction. The antigen was added in the zones of antigen and 
antibody excess and at the equivalence point. The incubation periods for the 
reactants varied from the 3  minute contact time technic to overnight.  Incu- 
bation temperatures were 37 °  C.,  20  °  C.,  and 4 ° C.  in different experiments. 
These combinations all resulted in failure to activate the protease precursor of 
the  rabbit  immune serum or globulin as determined by our casein digestion 
assay  method.  The  saline  controls  were  also  negative.  That  these  sera  did 
contain  a  protease precursor  was  demonstrated  by  adding  streptokinase  to 
aliquots of each sample and incubating under the same conditions. These sera 
treated  in  this  manner yielded protease activity of  7  to  13  units.  However, 
streptokinase did not  activate the  corresponding rabbit globulin fractions in 
confirmation of the findings of other investigators (I6, 18). 
Since  some  activators  of  serum  protease  are  known  to  possess  species 
specificity, experiments utilizing preformed precipitates also were carried out 
with immune rabbit globulin and immune rabbit serum. Again, to exclude the 
possible effect of protease inhibitors in the experiments involving whole rabbit 
serum, the 3 minute contact technic was employed. These experiments with the 
rabbit globulin and whole serum were performed under the same conditions as 
previously described in the studies on human protease. In these experiments as 
well,  no protease activation could be detected by the use  of preformed pre- 
cipitate  as  an  activator.  The  streptokinase  controls  showed  positive casein 
digestion only with the whole serum. Negative results were obtained when a 
fourfold concentrated rabbit globulin fraction was used, irrespective of the time 
of incubation of the reactants. Thus, regardless of the presence or absence of 
possible protease inhibitors of the serum, or of the duration of the incubation 
period,  no protease activation could be demonstrated by preformed antigen- 
antibody precipitates, or by antigen-antibody complexes formed in the presence 
of the precursor, even under conditions thought to be best suited for activation. 
Studies on Guinea Pig Serum Protease.--Since the results with human serum 
and with the rabbit antibody-antigen system resulted in no protease activation, 
investigations proceeded on a  guinea pig antibody-antigen system, which had 
been reported to result in protease activation (23). 
Preliminary experiments consisted of treating five guinea pigs with Merck's soluble egg 
albumin exactly as described by Ungar and Mist (23). The treatment  of five other guinea 
pigs varied from their  technic only in that crystalline ovalbumin replaced the crude egg 
albumin. In addition, five more animals received the same volume of saline in place of the 
antigen to serve as controls. Mter the time interval of 25 days as recommended  by the above 
authors, the serum of each animal was obtained by cardiac puncture. Antigen and saline  were 
added to separate aliquots of the sera of treated  and control animals, and the euglobulin 
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activation  by antigen or saline was done with our casein proteolytic method  instead of the 
fibrinogenolytic  method used by Ungar and Mist. A further aliquot of each serum was tested 
for precipitable antibodies by the ring test technic. 
TABLE I~ 
Effect of Antigen and Saline on Guinea Pig Serum Protease Activation 
Proteolytic  uuits~ 
guinea  pigs  o  ~ t  "  guinea  pigs 
..~  ,.~ 
15 
.15 
I 
.15 
,"  0.5 
.15 
1.8  1.5 
,15  ,15 
,15  ,15 
,"  0.5  1.C 
10  ,15  >15 
16i  ,15  715 
IZ  2.6  3.5; 
18  0  0 
19  0  0 
20  0  0 
0  0 
<0.5  <0.5 
23  0  0 
24  0  0 
25  <0.5  <0.5 
Males 
Females 2212 
ooq 
0  0 
0  0 
0  0 
°° I 
0  0 
0  ~0 
0  0 
0  0 
-  Males  11 
--  12 
--  13 
+  14 
--  15 
--  26 
--  27 
--  28 
--  29 
--  30 
--  Females 31 
32 
33 
34 
Fibrino- 
Proteolytic unitst  genolytic 
method§ 
,15 
,15 
~15 
~15 
,15 
,15 
5.4 
0 
1.0 
0 
2.7 
<0.5 
0 
0 
>15 
>15 
>15 
CO 
I 
1;,o 
0  0 
0  0 
0  0 
2,31  t  0  0 
<0.5  0 
0  0  0 
0  0  0 
* Pigs given a single injection of antigen. 
Data obtained by casein proteolysis method. 
§ Highest dilution which indicated  fibrinogenolysis by failure to clot upon addition  of 
thrombin. 
The results obtained with these animals (Nos.  1 to 15) are shown in Table 
III. It can be observed that no significant differences occurred in the degree of 
activation of serum protease for normal and treated  animals. Although the 
lack of serum prevented measuring titers beyond 15 units, it should be noted 
that three of the treated pigs showed less activation with the antigen than when 
saline was added to the sera. In treated guinea pig 4, there was no activation at 
all, regardless of the activating agent used. It also is of interest that with this 448  ACTIVATION  OF  SERU~  PROTEASE 
particular  set  of animals,  the  members  of the  control  group  all  showed as 
much (or more) protease activation as those of the treated groups. It therefore 
seems apparent that there was no significant difference in protease activation 
whether antigen or saline was added to the serum of either treated or normal 
animals. 
Because these results were divergent from those of Ungar and Mist who had 
reported  significant  protease  activation  with  the  antigen-treated  serum  as 
compared to their saline controls, the experiments were repeated with twenty 
new guinea pigs obtained from a  different source. 
Ten males and ten females were placed in separate cages. Five animals of each sex were 
randomly selected and injected with the soluble egg albumin antigen. The remaining animals 
were treated with saline and regarded as the control animals. The technic of Ungar and Mist 
was again carried out in as exact detail as possible. Since the possibility existed that their 
fibrinogenolytic method of protease assay might be measuring a different enzyme than the 
casein digestion method generally used here, both methods of protease assay were used on 
aU of the serum samples from these guinea pigs. 
The comparative data for animals  16 to 34 are  shown in Table III. It is 
worthy of note that whereas the first set of guinea pigs exhibited high values of 
protease activation,  the  second set of animals,  except for animal  16 demon- 
strated negative or low values of activity. The data obtained agree with the 
results obtained with the first set of guinea pigs 1 to 15 in that no difference in 
protease activity could be shown whether antigen or saline was added to serum 
samples from either  the albumin-injected or saline-injected animals.  The in- 
stances of demonstrable proteolytic activity may be explained by either the 
acidification  dilution  method  of  obtaining  the  euglobulin  fraction which  at 
times leads to spontaneous activation (17),  or possibly to shock due to trauma 
or hemorrhage (10,  49, 50)  occurring during cardiac puncture of the animal. 
The concurrent use of both assay methods also precludes the possibility that 
the failure to duplicate the results of Ungar and Mist may have been due to a 
substrate specificity of the protease activated. 
A possible explanation for the discrepancy of our results compared with those 
of the above authors may rest on the lack of sensitization of our animals as only 
in guinea pig 4 could precipitable antibodies be demonstrated (see Table III). 
To explore this possibility, the animals were reimmunized with the soluble egg 
albumin. 
With the first subcutaneous reinjection, one of the animais died of anaphylactic shock 
(No. 16) while another (No. 17) exhibited anaphylactic symptoms  with recovery.  The remain- 
ing animals were deiensitized with an 0.05 ml. (20 mg./ml.) injection  of the antigen. Succeed- 
ing subcutaneous inoculations were made without any further symptoms or fatalities. The 
injections were continued until positive precipitin titers were obtained. These animals also 
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Table IV records the results of assaying the attempted protease activation of 
the immune sera by antigen and by saline.  Again the results show no significant 
difference in the protease  activation whether antigen or saline was added to the 
serum of sensitized guinea pigs. The activity  of the sera of treated animals in 
this  experiment  corresponded  rather  closely to  that previously obtained  and 
shown in Table III, with the exceptions that pig  17 showed some decrease in 
TABLE IV 
A ctivatlon of Immune and Normal Guinea Pig Serum Protease 
Guinea pig serum 
(t.s ml.) 
Sensitized animals 
Males  17 
18 
19 
20 
Females 21 
22 
23 
24 
Controls 
Males  27 
28 
29 
Females 31 
32 
33 
Saline 
0 
0 
2.2 
0.7 
0 
0 
0 
<0.5 
Proteolytic units* 
Activators added to serums 
11.8 
0 
>15 
1.5 
2.2 
0 
Merck egg 
albumin 
0 
0 
1.4 
0 
0 
0 
0 
0 
4.6 
0 
>15 
4.1 
13.5 
0 
Staphylokinase 
>15 
>15 
>15 
>15 
>15 
>15 
>15 
Precipitin test 
+ 
++ 
+ 
+ 
++ 
++ 
++ 
+ 
h 
Results  obtained  with these sera by the fibrinogenolytic assay method were all negative 
except where staphylokinase was added. 
* Data obtained by casein proteolysis method. 
0.1 nag. antigen or 0.1 ml. saline or staphylokinase added per mL serum. 
activity and pig 19 some increase in activity. The serum of the control animals, 
however, seemed to show greater variability although  with no definite pattern. 
The activation of serum 31 and 32 would seem to be confirmatory evidence that 
the amount of egg albumin employed did not exhibit any inhibitory action on 
the possible activation of serum protease. 
As a control for the potential protease precursor in the serum, staphylokinase 
was used as an activator wherever enough serum  was available.  Strong pro- 
teolysis  of the  casein  substrate  was always  demonstrable  in  these  instances. 450  ACTIVATION  OF SERUM  PROTEASE 
As a further indication for the presence of the precursor, most of the euglobulin 
samples  derived from these  experiments were  treated  with  staphylokinase. 
Although the activity of these fractions did not yield as high an activity as the 
original whole serum, each sample thus treated exhibited significant protease 
activity compared with that of the saline-treated aliquots. The staphylokinase- 
treated samples ranged from 2 to 5 units while every saline-treated sample 
yielded zero units. 
DISCUSSION 
The experiments and results described in this study indicate that activation 
of serum protease by an antigen-antibody combination does not occur to any 
significant extent, at least in vitro. Although only one antigen was used in this 
study, the fact that negative results were obtained by the use of the sera of 
three different species would tend to discredit this type of reaction as being a 
general phenomenon.  Our  results  obtained with  the  rabbit  antiovalbumin- 
ovalbumin system are  in  direct  conformity with the results of  Geiger  (24) 
employing  this  combination as  one  of  his  immune  systems.  Furthermore, 
Geiger had shown that even the activation that can be effected with another 
immune system generally falls within the upper limits of spontaneous activation 
obtained with untreated and normal animals. 
The divergence of results obtained in this work from those of Ungar and Mist, 
involving activation of  guinea pig  serum protease  with  antigen cannot  be 
explained on the available evidence. Although Geiger confirmed the results of 
Ungar and Mist with mucopolysaccharides as guinea pig serum activators, he 
could not demonstrate the activation of rabbit serum with these preparations. 
He did not report any experiments employing guinea pig serum sensitized to 
egg albumin, although his results with rabbit serum sensitized to this antigen 
were negative. Furthermore, Mclntire and Roth  (51)  reported that the ad- 
dition of antigen to sensitized rabbit blood did not activate enough protease to 
cause detectable lysis of a plasma clot. 
Although Ungar and Mist reported their guinea pigs to be sensitized to egg 
albumin,  they  did  not  record  any  serological  studies  to  demonstrate  this 
sensitivity. In our study only one of twenty animals showed any precipitable 
antibodies (Table III) when immunized according to their method, and even 
this animal exhibited no specific protease activation. Thus, even though these 
authors did demonstrate the activation of the serum of their treated animals 
with antigen, one can not state unequivocally that this activation was due 
strictly to the antigen-antibody combination. It must be recognized, however, 
that there is great variability in the activation pattern of protease in individuals 
of the same species as seen in Tables Ill and IV. 
The early evidence previously cited on which much of the protease  theory of al- 
lergic reaction  is based  deserves comment.  Although Joblh~g et at.  (5, 6,  20)  had j.  v.  JEMSKI~ J.  A.  FLICK~ AND W.  R.  STINEBRING  451 
concluded  that particulate  matter or a  precipitin  reaction  resulted  in  serum pro- 
teolyfic activity which presumably yielded substances causing anaphylaxis, in none 
of their papers do they describe  the employment of an actual  precipitin  test as a 
confirmatory procedure. Their conclusions could not be substantiated  here as shown 
by the negative results obtained with  the numerous precipitin  tests carried out in 
this investigation. Negative results,  as well, were always obtained  in  the attempts 
to activate serum protease with preformed precipitates. 
The similar conclusions  of Bronfenbrenner  (21, 22)  have also  to  be reevaluated. 
He  immunized  animals  against  raw  egg white  and  demonstrated  precipitins  had 
formed against  the  antigen.  He reported  that  following  the  mixing  of  the  fresh 
immune serum with  homologous  antigen,  previously  boiled  for  30  minutes,  toxic 
substances  formed through  the  release  of proteolytic  "ferments" by this  antigen- 
antibody union.  Thus, Bronfenbrenner in considering  this a specific antigen-antibody 
reaction assumed that the specificity  of the antigen was not altered by the  bolting 
process.  However, Furth  (52-53)  reported profound changes  in  the antigenic struc- 
ture  of heated  proteins.  He demonstrated  that  antisera  to  native  crystalline  egg 
albumin would no longer react with egg albumin heated to 100°C. for only 5 minutes. 
He concluded a new specificity was produced by heating as demonstrated by anaphy- 
laxis,  Arthus  phenomenon,  and  precipitin  reactions.  There  is  still  the  possibility 
that  heat-stable antigens  exist  in  egg white  and  were  responsible  for  the  results 
obtained by Bronfenbrenner. 
Another point in opposition to the protease theory of allergy is that although 
protease  activation could not  be demonstrated  by our rabbit or guinea pig 
antiovalbumin-ovalbumin  systems,  severe Arthus  reactions  and precipitable 
antibodies  were  readily  demonstrated  in  the  first  mentioned  animals.  Ana- 
phylaxis as well as the Arthus phenomena and precipitable antibodies was also 
observed in the guinea pigs. If the release of protease was the significant factor 
involved in these reactions, it would seem, from a physiological point of view, 
that  in general all antigen-antibody systems should be capable of activating 
significantly large amounts of protease. This apparently does not hold true for 
it can be observed in Tables III and IV that no consistent differences occur in 
the content  of protease precursor in the normal or sensitized animals.  Euler 
and Heller (54) could find no difference in the amount of protease activation, 
using staphylokinase as an activator, between normal and hypersensitive rabbit 
euglobulin fractions. 
The results of this study therefore are further evidence against the activation 
of serum protease by an antigen-antibody combination. It would also seem that 
the protease content of serum during anaphylaxis is not primarily dependent 
upon an antigen-antibody union. 
SUMMARY 
The results obtained in this study indicate that serum protease is not acti- 
vated by either a  rabbit or guinea pig antiovalbumin-ovalbumin system, in 
vitro. 452  ACTIVATION  OF  SERUM  PROTEASE 
A precipitin reaction occurring in the presence of a serum protease precursor 
of three species (human, rabbit, and guinea pig) failed to activate the protease 
precursor.  Furthermore, particulate material as preformed precipitates could 
not be shown to activate the protease of either human or rabbit serum or their 
euglobulin fractions. 
The material presented seems to be further evidence against the postulated 
role of serum protease in immunologic systems. 
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